ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Programmable Klebsiella pneumoniae Phage Tropism Enabled by Scalable Receptor-Binding Protein Mining and Modular Assembly.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- Phage Therapy Enhanced by Using Engineered Bacteriophages: A Powerful Antibacterial Tool to Address the Dilemma Posed by Multidrug-Resistant Bacterial Infections.International journal of molecular sciences · 2026Review
- Modular plug-and-play engineering of Klebsiella phages with dual receptor-binding proteins for efficient host range design.Journal of biological engineering · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Phage therapy is an attractive countermeasure to multidrug-resistant pathogens, but clinical deployment is limited by the narrow and poorly predictable host range of most phages. Public repositories now house tens of thousands of phage genomes, yet there is no systematic route for turning this sequence space into designer phages with defined receptor specificities. Here we present a scalable, data-driven framework that converts receptor-binding protein (RBP) diversity into a modular toolkit for programmable phage engineering. Using Klebsiella pneumoniae as a model, we mined 280 non-redundant Przondovirus RBP sequences and resolved them into >50 discrete clusters. Functional screening of the Prz_RBPs from 41 previously uncharacterized Przondovirus phages expanded the number of experimentally validated capsular locus (KL) targets from 14 to 32 in Przondovirus. Each cluster was primarily associated with a dominant KL type, enabling construction of a genotype-to-phenotype map that accurately predicts receptor tropism. The identification of conserved anchor motifs enabled combinatorial pairing of Prz_RBP1 and Prz_RBP2 as plug-and-play modules for programmable phage tropism. Supplying exogenous Prz_RBP2 variants that assemble with Prz_RBP1 further and predictably expands host range, providing broad and tunable coverage. This framework transforms raw genomic diversity into customizable antibacterial agents and offers a general blueprint for precision phage therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.